GNMX
Aevi Genomic Medicine, Inc.
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
73 hedge funds and large institutions have $19.2M invested in Aevi Genomic Medicine, Inc. in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 9 closing their positions.
Holders
73
Holders Change
-3
Holders Change %
-3.95%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
21
Reduced
21
Closed
9
Calls
$2.74M
Puts
$549K
Net Calls
+$2.19M
Net Calls Change
-$4.06M
Top Buyers
| 1 |
1
BlackRock
New York
|
$3.75M |
| 2 |
BBA
2
Baker Bros. Advisors
New York
|
$3.01M |
| 3 |
3
Goldman Sachs
New York
|
$396K |
| 4 |
2L
4
22NW LP
Seattle,
Washington
|
$288K |
| 5 |
RFCA
5
R&F Capital Advisors
New York
|
$157K |
